Bui Lynne A. 4
4 · Hillstream BioPharma Inc. · Filed Mar 23, 2022
Insider Transaction Report
Form 4
Bui Lynne A.
Director
Transactions
- Award
Options (right to buy)
2022-03-21+50,000→ 50,000 totalExercise: $1.33Exp: 2032-03-21→ Common stock (50,000 underlying)
Footnotes (1)
- [F1]On March 21, 2022, the Reporting Person was granted options ("Options") to purchase up to 50,000 shares of the Registrant's common stock pursuant to the Registrant's 2019 Stock Incentive Plan. The Options vest in 12 equal monthly installments with the first installment vesting on the date of grant.